Tribunal fees scrapped in landmark court ruling

The fees, introduced by the coalition Government in 2013, meant that workers who had been treated unfairly or illegally were forced to pay up to £1,200 to take their employers to court.
Unison took the case to the Supreme Court, with lawyers arguing that the fees had been a huge expense for many low-paid employees and prevented people from gaining justice in the workplace – as evidenced by the 79% drop in cases being brought forward after the fees were introduced.
The UK’s highest court ruled in favour of the union, stating that the fees were “inconsistent with access to justice” and in conflicted with the Equality Act 2010 because they disproportionately affected women.
As a result of the victory, the Government is set to refund more than £27m to claimants in what Unison General Secretary Dave Prentis has described as “a major victory for employees everywhere”.
Commenting on the ruling, FDA General Secretary Dave Penman said: “I’d like to congratulate Unison for leading on this issue and ultimately winning this important victory for workers across the country.
“When the fees were introduced, the FDA took the decision to pay all tribunal costs on behalf of members, but not everybody has access to this kind of support.
“Unison’s hard work in pursuing this issue means many more people can now get access to the justice they deserve.”
Related News
-
FDA rejects claims civil service to blame for delays to Northern Ireland infrastructure projects
The FDA’s National Officer for Northern Ireland Robert Murtagh has spoken out against claims that the Northern Ireland Civil Service, were to blame for the failure of infrastructure projects to be completed on time.
-
Penman joins panel discussion on ethical leadership in government at IfG ‘Nolan Principles at 30’ conference
FDA General Secretary Dave Penman took part in a panel discussion covering the question ‘How can politicians demonstrate ethical leadership?’.
-
Carers Week 2025 – launching our Carers’ Survey
To mark Carers Week 2025 (9-15 June), the FDA is launching a survey of carers in the civil service to find out what progress has been made since our 2021 report, and what still needs to be done.